261 related articles for article (PubMed ID: 16388300)
1. Osteonecrosis of the jaws and bisphosphonates. Report of three cases.
Pastor-Zuazaga D; Garatea-Crelgo J; Martino-Gorbea R; Etayo-Pérez A; Sebastián-López C
Med Oral Patol Oral Cir Bucal; 2006 Jan; 11(1):E76-9. PubMed ID: 16388300
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases.
Dimitrakopoulos I; Magopoulos C; Karakasis D
Int J Oral Maxillofac Surg; 2006 Jul; 35(7):588-93. PubMed ID: 16687238
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma.
Diego R; D'Orto O; Pagani D; Agazzi A; Marzano U; Derada Troletti G; Fontanella W; Pignataro L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e1-5. PubMed ID: 17197204
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.
Marx RE; Sawatari Y; Fortin M; Broumand V
J Oral Maxillofac Surg; 2005 Nov; 63(11):1567-75. PubMed ID: 16243172
[TBL] [Abstract][Full Text] [Related]
5. Osteonecrosis of the jaw associated with bisphosphonate use: Presentation of seven cases and literature review.
Mortensen M; Lawson W; Montazem A
Laryngoscope; 2007 Jan; 117(1):30-4. PubMed ID: 17202926
[TBL] [Abstract][Full Text] [Related]
6. The incidence of jaw osteonecrosis in multiple myeloma patients treated with bisphosphonates.
Kraj M; Pogłód R; Maj S; Owczarska K
Acta Pol Pharm; 2006; 63(5):450-2. PubMed ID: 17357613
[No Abstract] [Full Text] [Related]
7. Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases.
Bagan JV; Jimenez Y; Murillo J; Hernandez S; Poveda R; Sanchis JM; Diaz JM; Scully C
Oral Oncol; 2006 Mar; 42(3):327-9. PubMed ID: 16275156
[No Abstract] [Full Text] [Related]
8. Bisphosphonates and osteonecrosis of the jaws: science and rationale.
Gutta R; Louis PJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):186-93. PubMed ID: 17448709
[TBL] [Abstract][Full Text] [Related]
9. [Osteonecrosis of the jaws: a secondary effect of bisphosphonates].
Schortinghuis J; Meijndert L; De Visscher JG; Witjes MJ
Rev Belge Med Dent (1984); 2007; 62(4):168-75. PubMed ID: 18506991
[TBL] [Abstract][Full Text] [Related]
10. Osteonecrosis and bisphosphonates in oral and maxillofacial surgery.
Chaudhry AN; Ruggiero SL
Oral Maxillofac Surg Clin North Am; 2007 May; 19(2):199-206, vi. PubMed ID: 18088878
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonates, osteonecrosis of the jaw, and dental treatment recommendations.
Radfar L; Masood F
J Okla Dent Assoc; 2008; 99(7):28-9. PubMed ID: 18595621
[TBL] [Abstract][Full Text] [Related]
12. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.
Friedrich RE; Blake FA
Anticancer Res; 2007; 27(4A):1841-5. PubMed ID: 17649782
[TBL] [Abstract][Full Text] [Related]
13. Association between osteonecrosis of the jaws and chronic high-dosage intravenous bisphosphonates therapy.
Graziani F; Cei S; La Ferla F; Cerri E; Itro A; Gabriele M
J Craniofac Surg; 2006 Sep; 17(5):876-9. PubMed ID: 17003614
[TBL] [Abstract][Full Text] [Related]
14. Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: Report of 3 cases.
Curi MM; Cossolin GS; Koga DH; Araújo SR; Feher O; dos Santos MO; Zardetto C
J Oral Maxillofac Surg; 2007 Feb; 65(2):349-55. PubMed ID: 17236949
[No Abstract] [Full Text] [Related]
15. Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment.
Ficarra G; Beninati F; Rubino I; Vannucchi A; Longo G; Tonelli P; Pini Prato G
J Clin Periodontol; 2005 Nov; 32(11):1123-8. PubMed ID: 16212571
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonate-associated osteonecrosis of the jaws: the limits of a conservative approach.
Tirelli G; Biasotto M; Chiandussi S; Dore F; De Nardi E; Di Lenarda R
Head Neck; 2009 Sep; 31(9):1249-54. PubMed ID: 19260132
[TBL] [Abstract][Full Text] [Related]
17. Dental extractions in patient treated with intravenous bisphosphonates and risk of osteonecrosis of jaws: presentation of a preventive protocol and case series.
Ferlito S; Liardo C; Puzzo S
Minerva Stomatol; 2010; 59(11-12):593-601. PubMed ID: 21217623
[TBL] [Abstract][Full Text] [Related]
18. Bisphosphonate-associated osteonecrosis of the jaw: conclusions based on an analysis of case series.
Landesberg R; Wilson T; Grbic JT
Dent Today; 2006 Aug; 25(8):52, 54-7. PubMed ID: 16925161
[TBL] [Abstract][Full Text] [Related]
19. Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases.
Alons K; Kuijpers SC; de Jong E; van Merkesteyn JP
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Feb; 107(2):e1-7. PubMed ID: 19071040
[TBL] [Abstract][Full Text] [Related]
20. Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report.
Merigo E; Manfredi M; Meleti M; Corradi D; Vescovi P
J Oral Pathol Med; 2005 Nov; 34(10):613-7. PubMed ID: 16202082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
